Risk-benefit analysis of using the middle fossa approach for acoustic neuromas with >10 mm cerebellopontine angle component.
about
Surgery of the ear and the lateral skull base: pitfalls and complications.Determining benchmarks in hearing preservation surgery for vestibular schwannomaChange in hearing and tinnitus in conservatively managed vestibular schwannomas.Hearing preservation surgery in vestibular schwannoma: the hidden truth.Total facial paralysis after vestibular schwannoma surgery: probability of regaining normal function.Facial nerve outcomes in middle cranial fossa vs translabyrinthine approaches.Vestibular schwannoma management: What is the 'best' option?Influence of nerve branch of origin and extracanalicular extension of the tumor on hearing after middle fossa removal of vestibular schwannoma.Diagnosis and therapy of vestibular schwannoma.Analysis of hearing preservation and facial nerve function for patients undergoing vestibular schwannoma surgery: the middle cranial fossa approach versus the retrosigmoid approach--personal experience and literature review.Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach.[Hearing results after middle fossa removal of small (T1/T2) vestibular schwannomas].Hearing preservation using combined monitoring of extra-tympanic electrocochleography and auditory brainstem responses during acoustic neuroma surgery.Is the middle fossa approach the treatment of choice for intracanalicular vestibular schwannoma?
P2860
Q30444643-7D346117-EAD5-42D1-A8C1-C2B497F04EE5Q30451557-071496D4-E8ED-437B-A885-DD86F06E1448Q30499034-A55EEE39-735B-4955-AA65-F34E480FEE22Q35680109-B1504845-E683-47CA-9458-DCD81DD53D2AQ35903924-0FE30757-D1A5-4AA0-9CD1-F0D37DA97382Q36344954-647696A7-BCD2-4029-8085-4923E44FF62EQ36385426-E5D2892A-4BA6-4C74-A90F-A6C717F65CADQ36939368-A0CFDCD8-B1EA-4D2C-8D44-77F4A6CD8959Q37578488-68E7C9C9-EB88-447E-BB9A-AA7456202114Q37914621-402CDBC8-0BB4-450D-95E3-1ED3ADF71D8EQ40400196-0E902933-EBE6-42EC-AD7A-71966F487917Q50422783-9E647F78-9C81-44E2-9CA7-F0B72B471E51Q50452416-B7073122-01BB-4ABF-B961-55E8F54C1E17Q50474406-C90ADF91-6164-4C90-8ACF-3FAE8D821272
P2860
Risk-benefit analysis of using the middle fossa approach for acoustic neuromas with >10 mm cerebellopontine angle component.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Risk-benefit analysis of using ...... ebellopontine angle component.
@ast
Risk-benefit analysis of using ...... ebellopontine angle component.
@en
Risk-benefit analysis of using ...... ebellopontine angle component.
@nl
type
label
Risk-benefit analysis of using ...... ebellopontine angle component.
@ast
Risk-benefit analysis of using ...... ebellopontine angle component.
@en
Risk-benefit analysis of using ...... ebellopontine angle component.
@nl
prefLabel
Risk-benefit analysis of using ...... ebellopontine angle component.
@ast
Risk-benefit analysis of using ...... ebellopontine angle component.
@en
Risk-benefit analysis of using ...... ebellopontine angle component.
@nl
P2093
P1433
P1476
Risk-benefit analysis of using ...... ebellopontine angle component.
@en
P2093
Bulent Satar
John Oghalai
Lawrence H Pitts
Philip D Yates
Robert K Jackler
P304
P356
10.1097/00005537-200208000-00031
P407
P433
P577
2002-08-01T00:00:00Z